Severe delayed hemolytic transfusion reaction secondary to anti-Ata

Authors

  • K.L. Cash,

    1. From the Departments of Pathology and Medicine, Albert Einstein College of Medicine and Montefiore Medical Center, Bronx, New York; and The Immunohematology Reference Laboratory of the New York Blood Center, New York, New York.
    Search for more papers by this author
  • T. Brown,

    1. From the Departments of Pathology and Medicine, Albert Einstein College of Medicine and Montefiore Medical Center, Bronx, New York; and The Immunohematology Reference Laboratory of the New York Blood Center, New York, New York.
    Search for more papers by this author
  • L. Sausais,

    1. From the Departments of Pathology and Medicine, Albert Einstein College of Medicine and Montefiore Medical Center, Bronx, New York; and The Immunohematology Reference Laboratory of the New York Blood Center, New York, New York.
    Search for more papers by this author
  • J. Uehlinger,

    1. From the Departments of Pathology and Medicine, Albert Einstein College of Medicine and Montefiore Medical Center, Bronx, New York; and The Immunohematology Reference Laboratory of the New York Blood Center, New York, New York.
    Search for more papers by this author
  • L.J. Reed

    1. From the Departments of Pathology and Medicine, Albert Einstein College of Medicine and Montefiore Medical Center, Bronx, New York; and The Immunohematology Reference Laboratory of the New York Blood Center, New York, New York.
    Search for more papers by this author

  • Address correspondence to: Kevin L. Cash, MD, Blood Bank, Montefiore Medical Center, 111 East 210th Street, Bronx, NY 10467; e-mail: kcash@montefiore.org. No reprints available.

Abstract

BACKGROUND: Anti-Ata is a rare red cell (RBC) alloantibody found in the black population. It has been described as causing one case of mild hemolytic disease of the newborn, but its ability to cause hemolytic transfusion reactions is uncertain.

CASE REPORT: The patient was a 60-year-old black female with a history of three uneventful pregnancies but no transfusions. On admission, her direct and indirect antiglobulin tests were negative, total bilirubin was 0.5 mg per dL, and lactate dehydrogenase was 224 IU per L. She received nine units of compatible RBCs in the perioperative period of a hemicolectomy. Her hemoglobin rose appropriately and stabilized at 12.6 g per dL by the 6th postoperative day. By Day 10 after surgery her hemoglobin had dropped to 6.8 g per dL, and her total bilirubin and lactate dehydrogenase had risen to 1.4 mg per dL and 783 IU per L, respectively. The direct and indirect antiglobulin tests were now newly positive with strengths of 3+. A warm hemolytic autoantibody was suspected. She was transfused two units of incompatible RBCs for a rapidly falling hemoglobin and symptomatic anemia. On Day 11, the total bilirubin rose to 3.5 mg per dL, and the lactate dehydrogenase was 1154 IU per L with a hemoglobin of 7.6 g per dL. Corticosteroids were begun. Studies of serum and an acid eluate revealed anti-Ata, but no other RBC antibodies. The patient stabilized, and further transfusion was avoided.

CONCLUSION: Although anti-Ata was previously described as being of uncertain clinical significance, this patient demonstrated the ability of the antibody to cause a severe delayed hemolytic transfusion reaction.

Ancillary